Tag Archives: San Francisco California

Oncologists are now faced with the challenge of understanding how specialized drugs can strike tumor stem cells and impair their ability to replicate and spread. This is one of the most important questions that researchers will have to answer in upcoming years according to Regina Elena Institute hematologist Michele Milella. In San Francisco at the American Society of Hematology (ASH) Congress Milella spoke about future hematology issues, including fighting blood borne tumors with stem cell transplants over the past years.

“The ASH in this sense is an excellent indicator for where research is going, and Read More…

A study on mice directed by Alessandra Sacco of Stanford University has shown that once inserted into a diseased muscle, just one adult muscular stem cell can reproduce to form an entire ‘family’ of cells and restore lost muscular function. In a leg muscle with no muscular stem cells that has been irreversibly damaged, a single adult stem cell can take root and multiply, restoring muscular function.

The study was presented today in the Annual Meeting of the American Society of Cell Biology
(ASCB) in San Francisco. The muscular stem cells in this case are called Read More…

An agreement on funding stem cell research is closer than previously thought. A change in direction on financing stem cell research by US President Barack Obama has excited the American scientific community, starting with the major universities in California, including the San Francisco State, San Jose’ University, Stanford, and Berkeley. This time it will be the California Institute of Regenerative Medicine (CIRM) to open its wallet, ready to fund grants worth 58 million dollars to groups and researchers studying stem cells.

Rhode Island-based biotechnology company MultiCell Technologies Inc. is teaming up with Maxim Biotech Inc. under cooperative research and development agreement to develop products for studying liver stem cells and liver cancer.

MultiCell (OTC: MCET), based in Woonsocket, owns exclusive rights to two issued U.S. patents, one U.S. patent application and a handful of corresponding foreign patents and patent applications regarding the isolation and differentiation of liver stem cells.

No financial details of the agreement with South San Francisco-based Maxim Biotech were disclosed. The deal will initially focus on creating a family of research reagent tool kits which can be used to Read More…

A new experimental technique in the future will remove skin cells from HIV patients, manipulate the cells bringing them to a state similar to that of stem cells, and then re-implant them in the same patient to eliminate the virus. The technique is still in the experimental phase in mice, but according to Gerhard Bauer, presenting the initial results of his study today at the 50th American Society of Hematology Congress in San Francisco, it’s a possibility. Bauer has been working for more than 10 years on this technique together with Read More…

Stem cells are basic cells that can become almost any type of cell in the body. Human stem cells can come from an embryo or an adult human. They have many possible uses in science and medicine, yet controversy surrounds them.

New research has identified rogue cells -- namely brain and muscle cells -- lurking within kidney organoids. Such cells make up only 10 to 20 percent of an organoid's cells, but their presence indicates that the 'recipes' used to coax stem cells into becoming kidney cells inadvertently are churning out other cell types.

A new study shows that cancer stem cells switch from metabolizing sugar to metabolizing protein. Clinical trial based on this observation may revolutionize care for older adults with acute myeloid leukemia.

Researchers have developed a way to grow human heart tissue that can serve as a model for the upper chambers of the heart, known as the atria. The tissue, derived from human induced pluripotent stem cells (hiPCSs), beats, expresses genes, and responds to drugs in a manner similar to a real human atrium. The model […]

Scientists have created a tiny, biodegradable scaffold to transplant stem cells and deliver drugs, which may help treat Alzheimer's and Parkinson's diseases, aging brain degeneration, spinal cord injuries and traumatic brain injuries. Stem cell transplantation, which shows promise as a treatment for central nervous system diseases, has been hampered by low cell survival rates, incomplete […]

Promising findings from preclinical animal studies show the potential of gene therapy for treating incurable neurological disorders. Scientists have successfully used gene therapy to slow the progression and improve symptoms of disorders such as amyotrophic lateral sclerosis and Parkinson's disease.

A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia type 7 (SCA7) and validates a new form of therapy with the potential to treat neurogenetic diseases effectively and with […]